Literature DB >> 17883407

Interaction between BDNF Val66Met and childhood trauma on adult's violent suicide attempt.

N Perroud1, P Courtet, I Vincze, I Jaussent, F Jollant, F Bellivier, M Leboyer, P Baud, C Buresi, A Malafosse.   

Abstract

Genetic factors, specially those related to serotoninergic activities, and childhood maltreatment have both been implicated in suicidal behaviour (SB). However, little attention has been paid to the possible interaction between genes and childhood maltreatment in the comprehension of SB. Brain-derived neurotrophic factor (BDNF) plays an important role in the growth of serotoninergic neurons during childhood and therefore is a good candidate for studies on SB. Moreover, decreased levels of BDNF have been found in the prefrontal cortex of suicide victims. In our study we wanted to see if Val66Met (a BDNF functional single-nucleotide polymorphism) could moderate the effect of childhood maltreatment on the onset, number and violence of SB in a sample of 813 Caucasian suicide attempters. Childhood maltreatment was evaluated using the Childhood Trauma Questionnaire. We used a regression framework to test the interaction between Val66Met and childhood maltreatment. Childhood sexual abuse was associated with violent suicide attempts (SA) in adulthood only among Val/Val individuals and not among Val/Met or Met/Met individuals (P = 0.05). The severity of childhood maltreatment was significantly associated with a higher number of SA and with a younger age at onset of suicide attempt. This result suggests that Val66Met modulates the effect of childhood sexual abuse on the violence of SB. It is proposed that childhood sexual abuse elicits brain structural modifications through BDNF dysfunction and enhances the risk of violent SB in adulthood.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17883407     DOI: 10.1111/j.1601-183X.2007.00354.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  30 in total

1.  Does prior traumatization affect the treatment outcome of CBT for panic disorder? The potential role of the MAOA gene and depression symptoms.

Authors:  Sebastian Trautmann; Jan Richter; Markus Muehlhan; Michael Höfler; Hans-Ulrich Wittchen; Katharina Domschke; Andreas Ströhle; Alfons O Hamm; Heike Weber; Tilo Kircher; Volker Arolt; Alexander L Gerlach; Georg W Alpers; Thomas Fydrich; Thomas Lang; Andreas Reif
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-07-15       Impact factor: 5.270

Review 2.  Neuropathology of suicide: recent findings and future directions.

Authors:  P-E Lutz; N Mechawar; G Turecki
Journal:  Mol Psychiatry       Date:  2017-07-11       Impact factor: 15.992

3.  GABAergic control of depression-related brain states.

Authors:  Bernhard Luscher; Thomas Fuchs
Journal:  Adv Pharmacol       Date:  2015-01-14

4.  Brain-derived neurotrophic factor (BDNF) Val66Met and adulthood chronic stress interact to affect depressive symptoms.

Authors:  Rong Jiang; Beverly H Brummett; Michael A Babyak; Ilene C Siegler; Redford B Williams
Journal:  J Psychiatr Res       Date:  2012-11-08       Impact factor: 4.791

5.  Association between Val66Met brain-derived neurotrophic factor (BDNF) gene polymorphism and post-treatment relapse in alcohol dependence.

Authors:  Marcin Wojnar; Kirk J Brower; Stephen Strobbe; Mark Ilgen; Halina Matsumoto; Izabela Nowosad; Elzbieta Sliwerska; Margit Burmeister
Journal:  Alcohol Clin Exp Res       Date:  2009-01-27       Impact factor: 3.455

6.  COMT but not serotonin-related genes modulates the influence of childhood abuse on anger traits.

Authors:  N Perroud; I Jaussent; S Guillaume; F Bellivier; P Baud; F Jollant; M Leboyer; C M Lewis; A Malafosse; P Courtet
Journal:  Genes Brain Behav       Date:  2009-10-23       Impact factor: 3.449

Review 7.  Gene-environment studies and borderline personality disorder: a review.

Authors:  Ryan W Carpenter; Rachel L Tomko; Timothy J Trull; Dorret I Boomsma
Journal:  Curr Psychiatry Rep       Date:  2013-01       Impact factor: 5.285

8.  Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran.

Authors:  Philippe Courtet
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

Review 9.  Imaging phenotypes of major depressive disorder: genetic correlates.

Authors:  J B Savitz; W C Drevets
Journal:  Neuroscience       Date:  2009-04-07       Impact factor: 3.590

10.  Brain-derived neurotrophic factor: role in depression and suicide.

Authors:  Yogesh Dwivedi
Journal:  Neuropsychiatr Dis Treat       Date:  2009-08-20       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.